Viewing StudyNCT06411691



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06411691
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-07
First Post: 2024-05-08

Brief Title: KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08
Start Date Type: ESTIMATED
Primary Completion Date: 2027-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-08
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-08
First Submit QC Date: May 8 2024
Study First Post Date: 2024-05-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-23
Last Update Post Date: 2024-06-07
Last Update Post Date Type: ACTUAL